A pilot study on the cutaneous toxicities in oncology patients on Epidermal Growth Factor Receptor inhibitors: skin physiology, clincial manifestations and quality of life.
Not Applicable
- Conditions
- Cutaneous side effects on oncology patients on EGFRIsSkin - Normal skin development and function
- Registration Number
- ACTRN12608000265370
- Lead Sponsor
- inda Wang
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Oncology patients about to start EGFRIs
male or female
aged 18 years or above
willing to give informed consent
Exclusion Criteria
Younger than 18 years of age
severe underlying disease that may interfere with the testing or test results
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method